Hormonal and biochemical parameters in polyhydramnios. 1987

I Phocas, and E Salamalekis, and A Sarandakou, and P A Zourlas
2nd Department of Obstetrics and Gynaecology, Medical School, University of Athens, Areteion Hospital, Greece.

Fifteen consecutive cases of polyhydramnios (PH) out of a total number of 8806 deliveries performed between the 28th and the 41st week of pregnancy were investigated during the period from 1979 to 1985. Three cases of acute PH and 12 cases of chronic PH of which 10 were idiopathic were distinguished. From the time the clinical diagnosis was established until delivery, maternal serum and amniotic fluid alpha-fetoprotein (AFP) and prolactin (PRL), as well as maternal serum oestrogens (OT), placental lactogen (HPL), chorionic gonadotropin (hCG) and pregnancy-specific beta 1-glycoprotein (SP1), were studied. A very high increase of maternal serum AFP in all the cases of PH was observed (p less than 0.001) and was associated with the high degree of risk for obstetrical complications, while, on the other hand, amniotic fluid AFP was increased only in PH associated with congenital abnormalities of the fetus. Maternal serum PRL was not different from normal values (p greater than 0.2), while amniotic fluid PRL was lower in all the cases of chronic idiopathic polyhydramnios studied. The protein hormones and the oestrogens showed a discrepancy in their elevation, according to the kind of PH, the outcome of pregnancy, and the condition of the infant at birth.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D010926 Placental Hormones Hormones produced by the placenta include CHORIONIC GONADOTROPIN, and PLACENTAL LACTOGEN as well as steroids (ESTROGENS; PROGESTERONE), and neuropeptide hormones similar to those found in the hypothalamus (HYPOTHALAMIC HORMONES). Hormones, Placental
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011256 Pregnancy Outcome Results of conception and ensuing pregnancy, including LIVE BIRTH; STILLBIRTH; or SPONTANEOUS ABORTION. The outcome may follow natural or artificial insemination or any of the various ASSISTED REPRODUCTIVE TECHNIQUES, such as EMBRYO TRANSFER or FERTILIZATION IN VITRO. Outcome, Pregnancy,Outcomes, Pregnancy,Pregnancy Outcomes
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D004967 Estrogens Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds. Estrogen,Estrogen Effect,Estrogen Effects,Estrogen Receptor Agonists,Estrogenic Agents,Estrogenic Compounds,Estrogenic Effect,Estrogenic Effects,Agents, Estrogenic,Agonists, Estrogen Receptor,Compounds, Estrogenic,Effects, Estrogen,Effects, Estrogenic,Receptor Agonists, Estrogen
D005260 Female Females
D006728 Hormones Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. Hormone,Hormone Receptor Agonists,Agonists, Hormone Receptor,Receptor Agonists, Hormone
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006831 Polyhydramnios A condition of abnormally high AMNIOTIC FLUID volume, such as greater than 2,000 ml in the LAST TRIMESTER and usually diagnosed by ultrasonographic criteria (AMNIOTIC FLUID INDEX). It is associated with maternal DIABETES MELLITUS; MULTIPLE PREGNANCY; CHROMOSOMAL DISORDERS; and congenital abnormalities. Hydramnios

Related Publications

I Phocas, and E Salamalekis, and A Sarandakou, and P A Zourlas
January 1980, International journal of fertility,
I Phocas, and E Salamalekis, and A Sarandakou, and P A Zourlas
April 1980, AMB : revista da Associacao Medica Brasileira,
I Phocas, and E Salamalekis, and A Sarandakou, and P A Zourlas
January 1997, Revista do Hospital das Clinicas,
I Phocas, and E Salamalekis, and A Sarandakou, and P A Zourlas
January 1991, Minerva endocrinologica,
I Phocas, and E Salamalekis, and A Sarandakou, and P A Zourlas
January 1989, Progress in clinical and biological research,
I Phocas, and E Salamalekis, and A Sarandakou, and P A Zourlas
July 1978, Angiology,
I Phocas, and E Salamalekis, and A Sarandakou, and P A Zourlas
July 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research,
I Phocas, and E Salamalekis, and A Sarandakou, and P A Zourlas
October 1999, The Journal of clinical endocrinology and metabolism,
I Phocas, and E Salamalekis, and A Sarandakou, and P A Zourlas
September 2014, Wilderness & environmental medicine,
I Phocas, and E Salamalekis, and A Sarandakou, and P A Zourlas
June 1990, Maturitas,
Copied contents to your clipboard!